文献速递头颈外科

手术治疗的人乳头瘤病毒相关N3期口咽鳞状细胞癌的结局

Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
PubMed 文献 · Laryngoscope · 2016-12-23

这项回顾性病例系列纳入1998年至2013年39例人乳头瘤病毒相关口咽鳞状细胞癌且病理N3期淋巴结病变患者,均接受手术伴或不伴辅助治疗。5年疾病特异性生存率、总生存率和无病生存率分别为89%、87%和84%,复发率为10%;病理阳性淋巴结少于5枚者无病生存率更优(P=0.041)。

要点

  • 人乳头瘤病毒相关口咽鳞状细胞癌病理N3期患者术后5年疾病特异性生存率89%。
  • 病理阳性淋巴结少于5枚者无病生存率更优(P=0.041)。
  • 复发率10%,其中区域复发5%、远处转移5%。

核心结论

  • 人乳头瘤病毒相关口咽鳞状细胞癌伴病理N3期淋巴结病变患者接受手术和辅助治疗后长期生存和区域控制非常有利。
  • 病理阳性淋巴结5枚或以上的患者复发风险可能更高。

研究设计与样本

  • 回顾性病例系列,附病历回顾,研究于1998年至2013年开展。
  • 纳入39例人乳头瘤病毒相关口咽鳞状细胞癌伴病理N3期淋巴结病变、接受手术伴或不伴辅助治疗的患者。
  • 主要结局为疾病特异性生存率,次要结局包括总生存率、无病生存率、不良事件和胃造瘘管率。

主要发现

  • 39例患者中36例(90%)接受了辅助治疗。
  • 中位随访39个月(范围2-147个月),平均年龄56岁,87%为男性。
  • 17例(44%)行选择性颈清扫,6例(15%)行根治性(2例)或扩大根治性(4例)颈清扫,92%存在包膜外侵犯。
  • 5年Kaplan-Meier估计疾病特异性生存率89%(95%CI:79%-99%),总生存率87%(95%CI:75%-99%),无病生存率84%(95%CI:72%-96%)。
  • 复发率10%(区域复发5%,远处转移5%);病理阳性淋巴结少于5枚者无病生存率更优(P=0.041)。

关键数值与推荐

  • 病理阳性淋巴结少于5枚者无病生存率更优(P=0.041)。
  • 病理阳性淋巴结5枚或以上的患者复发风险可能更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: To evaluate outcomes for patients with pathological N3 (pN3) neck disease from human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) and determine variables predictive of survival. STUDY DESIGN: Retrospective case series with chart review. METHODS: This study was conducted between 1998 and 2013 and included patients with HPV-related OPSCC treated with surgery with or without adjuvant therapy and who had pN3 nodal disease. The primary outcome was disease-specific survival (DSS). Secondary outcomes included overall survival (OS), disease-free survival (DFS), adverse events, and gastrostomy tube rates. RESULTS: Thirty-nine patients were included, of whom 36 (90%) underwent adjuvant therapy. Median follow-up was 39 months (range, 2-147 months). Mean age was 56 years, and 87% were male. Seventeen patients (44%) underwent selective neck dissection, whereas six (15%) underwent radical (n = 2) or extended radical (n = 4) neck dissection. Ninety-two percent had extracapsular extension. Five-year Kaplan-Meier estimated DSS, OS, and DFS were 89% (95% confidence interval [CI]: 79%-99%), 87% (95% CI: 75%-99%), and 84% (95% CI: 72%-96%), respectively. The disease recurrence rate was 10% (5% regional, 5% distant metastasis). Patients with less than 5 pathologically positive lymph nodes (P = .041) had improved DFS. CONCLUSIONS: Patients with HPV-related OPSCC and pN3 nodal disease treated with surgery and adjuvant therapy have very favorable long-term survival and regional control. Patients with five or more pathologically positive lymph nodes may be at higher risk for recurrence. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:2033-2037, 2017.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Zenga J, Haughey BH, Jackson RS, et al. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease. Laryngoscope. 2016. PMID: 28008626. doi:10.1002/lary.26455

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。